Emergence of Mycobacterium tuberculosis with Extensive Resistance to Second-Line Drugs — Worldwide, 2000–2004. Morbidity and Mortality Weekly Report, 55(11): 301-305, March 24, 2006.

During November 2004 - November 2005, CDC and WHO surveyed an international network of TB laboratories to assess the frequency and distribution of extensively drug-resistant (XDR) TB cases. This report summarizes the results of that survey.

Author:

Centers for Disease Control and Prevention (CDC), US Department of Health and Human Services, Public Health Service, Centers for Disease Control and Prevention (CDC), National Center for Health Statistics, Office of the Morbidity and Mortality Weekly Report Series, CDC MMWR

Format:

Report

Publication Date:

2006

ID:

33001

Audiences

Policy Makers

Focus Area

TB

Topic

MDR TB

Related Materials

Materials

Reimagining Medicaid, How Medicaid Can Help Address Social Determinants of Health

Materials

Global tuberculosis report 2023

Materials

Reported Tuberculosis in the United States, 2022

Materials

Reported Tuberculosis in the United States, 2020

Back to Results

Emergence of Mycobacterium tuberculosis with Extensive Resistance to Second-Line Drugs — Worldwide, 2000–2004. Morbidity and Mortality Weekly Report, 55(11): 301-305, March 24, 2006.

Related Materials

CDC NPIN Resources